Sat, Aug 2, 2014, 1:19 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • akos103 akos103 Jan 11, 2012 3:45 PM Flag

    Bank of America reaffirms buy

    Bank of America (BAC) Analysts Reiterate a “Buy” Rating on Optimer Pharmaceutic (OPTR)

    Posted by LUSA Staff on Jan 11th, 2012 // No Comments

    Optimer Pharmaceutic (NASDAQ: OPTR)‘s stock had its “buy” rating reaffirmed by analysts at Bank of America (NYSE: BAC) in a research report issued to clients and investors on Wednesday

12.780.00(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT
Tesla Motors, Inc.
NasdaqGSFri, Aug 1, 2014 4:00 PM EDT